Entcof Syrup is a combination expectorant and bronchodilator formulation containing Ambroxol (15mg/5ml), Guaifenesin (50mg/5ml), and Terbutaline (1.25mg/5ml). Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Guaifenesin serves as an expectorant, promoting the hydration of respiratory secretions and enhancing mucociliary clearance, which aids in the effective removal of mucus. Terbutaline, a selective beta-2 adrenergic receptor agonist, provides bronchodilation by relaxing smooth muscle in the airways, thus alleviating bronchospasm and improving airflow. This synergistic combination is indicated for the symptomatic relief of productive cough associated with acute and chronic respiratory conditions such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Entcof Syrup facilitates easier expectoration, reduces airway obstruction, and improves respiratory function. It should be used under medical supervision, with dosage adjusted according to patient age and clinical response. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component. Common adverse effects may include tremors, palpitations, or gastrointestinal discomfort. Entcof Syrup offers a comprehensive approach to managing respiratory symptoms by targeting mucus viscosity, secretion clearance, and bronchial smooth muscle relaxation.